Publications by authors named "Gail Broder"

Claim this Profile
A
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data.
Shelly Karuna, Fatima Laher, Sufia Dadabhai, Pei-Chun Yu, Doug Grove, Gail Broder

J Int AIDS Soc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid development of a registry to accelerate COVID-19 vaccine clinical trials.
Neil F Abernethy, Kylie McCloskey, Meg Trahey, Laurie Rinn, Gail Broder

NPJ Digit Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085.
Deborah A Theodore, Moni Neradilek, Kevin Gillespie, Srilatha Edupuganti, Juan Carlos Hinojosa, Gail Broder

J Acquir Immune Defic Syndr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Development of a Registry to Accelerate COVID-19 Vaccine Clinical Trials.
Neil F Abernethy, Kylie McCloskey, Meg Trahey, Laurie Rinn, Gail B Broder

Res Sq· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
Michele P Andrasik, Gail B Broder, Stephaun E Wallace, Richa Chaturvedi, Nelson L Michael

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
Srilatha Edupuganti, Nyaradzo Mgodi, Shelly T Karuna, Philip Andrew, Erika Rudnicki, Gail B Broder

J Acquir Immune Defic Syndr· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.
Gail B Broder, Jonathan P Lucas, Jontraye Davis, Stephaun E Wallace, Nandisile Luthuli

PLoS One· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stigma, Implicit Bias, and Long-Lasting Prevention Interventions to End the Domestic HIV/AIDS Epidemic.
Michele Andrasik, Gail Broder, Linda Oseso, Stephaun Wallace, Francisco Rentas

Am J Public Health· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.
Michele Andrasik, Doug Grove, Gail Broder, Hyman Scott, Mary Allen

Vaccine· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
Katherine Foy Huamani, Barbara Metch, Gail Broder, Michele Andrasik

Public Health Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
Rona L Siskind, Michele Andrasik, Shelly T Karuna, Gail B Broder, Clare Collins

J Acquir Immune Defic Syndr· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
Jonathan D Fuchs, Ian Frank, Marnie L Elizaga, Mary Allen, Nicole Frahm, Gail Broder

Open Forum Infect Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial.
Liza Dawson, Sam Garner, Chuka Anude, Paul Ndebele, Shelly Karuna, Gail Broder

Clin Trials· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials.
Michele Peake Andrasik, Ro Yoon, Jessica Mooney, Gail Broder, Marcus Bolton

Prev Sci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.
Jonathan D Fuchs, Magdalena E Sobieszczyk, Tamra Madenwald, Doug Grove, Shelly T Karuna, Gail Broder

J Acquir Immune Defic Syndr· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis